Evaluation of pharmaceutical quality of mesalamine delayed release tablets using a new high sensitivity reversed-phase UPLC method for its genotoxic/aniline impurity

E-Journal of Chemistry

Volumn 8, Issue 1, 2011, Pages 167-179

  Trivedi, Rakshit Kanubhai ^a   Patel, Mukesh C ^b  

^a DR REDDY'S LABORATORIES LTD   (India)

^b PS Science and HDPatel Arts College   (India)

Author keywords

5 aminosalicylic acid; Aniline; Genotoxicity; Mesalamine; UPLC

Indexed keywords

EID: 79951628127     PISSN: None     EISSN: 09734945     Source Type: Journal    
DOI: 10.1155/2011/953235     Document Type: Article

References (26)

1. Gisbert J P, Gomollon F, Mate J and Pajares J M, A Systematic Review Dig Dis Sci., 2002, 47, 471-488.
2. Klotz U, Eur J Clin Pharmacol., 2000, 56, 353-362.
3. De Vos M, Clin Pharmacokinetics, 2000, 39, 85-97.
4. Pappercorn M A and Goldman P, Gestroenterology, 1973, 64(2), 240-245.
5. Haagen Nielsen O and Bondesen S, Br J Clin Pharmacol., 1983, 16(6), 738-740.
6. Schröder H, Compbell D E S, Clin Pharmacol Ther., 1972, 13(4), 539-551.
7. th Ed., Pergamon, 1990, p.650.
8. st Ed.,) Martindale, The Extra Pharmacopoeia., Royal Pharmaceutical Society, London, 1996, p.1227.
9. Genotoxic and Carcinogenic impurities in drug Substances and Products: Recommended approaches. FDA Centre for Drug Evaluation and Research Guidance for Industries (Draft), 03 December 2008.
10. Ernst M. Bomhard and Bernd A. Herbold., Critical Reviews in Toxicology, 2005, 35(10), 783-835.
11. Ken-ichi Masumura, Yukari Totsuka, Keiji Wakabayashi and Takehiko Nohmi., Carcinogenesis, 2003, 24(12), 1985-1993.
12. Toshihiko Kawamori, Yukari Totsuka, Naoaki Uchiya, Tomohiro Kitamura, Hideyuki Shibata, Takashi Sugimura and Keiji Wakabayashi., Carcinogenesis, 2004, 25(10), 1967-1972.
13. Meiping Zhao, Xinxiang Zhang, Yuanzong Li and Wenbao Chang, Anal Lett., 2000, 33(14), 3067-3075.
14. Rahim S A, Nada D. Ismail and Bashir W A, Microchimica Acta, 1986, III, 417-423.
15. Zhao X and Suo Y, J Separ Sci., 2008, 31(4), 646-658.
16. Xiao-Lan Chen, Zhong-Bao Li, Ya-Xian Zhu and Jin-Gou Xu, Anal Chim Acta, 2004, 505(2), 283-287.
17. Jun Ping Xiao, Qing Xiang Zhou, Xiao Ke Tian, Hua Hua Bai and Xian Fa Su, Chin Chem Lett., 2007, 18(6), 730-733.
18. John McDonald, Andrew Mc Intyre, Michael L. Hitchman and David Littlejohn, Appl Spectrosc, 1998, 52(6), 908-911.
19. Cheing-Tong Yan and Jen-Fon Jen, J Chromatographia, 2004, 59(7-8), 517-520.
20. Liu X., Spectroscopy and Spectral Analysis, 2006, 26(6), 1141-1144.
21. Sarafraz Yazdi A and Es'haghi Z, J Chromatographia, 2006, 63(11-12), 563-569.
22. Reig, N. Calaf, R. E. Messegure, A. Morato, A. Escabros, J. Gelpi, E. Abian., J Mass Spectrom., 2007, 42(4), 527-541.
23. Mortensen S K, Trier X T Foverskov A and Petersen, J Chromatogr A., 2005, 1091(1-2), 40-50.
24. United States Pharmacopeia, USP32-NF27, p.2894.
25. British Pharmacopeia, BP- 2010, p.1368.
26. ICH, Validation of Analytical Procedure, Text and Methodology Q2(R1), International Conference on Harmonization, IFPMA, Geneva, 2005.